The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of TG02 plus dose-dense or metronomic temozolomide for recurrent anaplastic astrocytoma and glioblastoma in adults.
 
Jing Wu
No Relationships to Disclose
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim; Midas Medical Technologies; Salzman Group
 
Christine Cordova
Honoraria - Cook Medical (I)
Consulting or Advisory Role - Biodesix (I)
Travel, Accommodations, Expenses - Auris (I); Intuitive Surgical (I)
 
Orwa Aboud
No Relationships to Disclose
 
Marta Penas-Prado
Consulting or Advisory Role - AGIOS; Lilly
Research Funding - Abbvie (Inst); Agios (Inst); AROG (Inst); DelMar Pharmaceuticals (Inst); DNAtrix (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Novartis (Inst); Orbus Therapeutics (Inst)
 
Brett James Theeler
No Relationships to Disclose
 
Christine Bryla
Stock and Other Ownership Interests - Johnson & Johnson
 
Yu-Ting Su
No Relationships to Disclose
 
Ewa Grajkowska
No Relationships to Disclose
 
Ann McCoy
No Relationships to Disclose
 
Lisa Boris
No Relationships to Disclose
 
Christine Siegel
No Relationships to Disclose
 
Ramya Antony
No Relationships to Disclose
 
Nancy Garren
No Relationships to Disclose
 
Tracy Lawhon
Employment - Adastra Pharmaceuticals
Leadership - Adastra Pharmaceuticals
Stock and Other Ownership Interests - Adastra Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Adastra Pharmaceuticals
 
Terri Armstrong
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose